[O13] Oral Session 13　Lung Cancer / Thoracic Cancer 3（Rare gene alterations）
【E】

[O13-4] Efficacy and intracranial activity of tepotinib in Japanese patients with MET exon 14 skipping (METex14) NSCLC (VISION)

^○Masahiro Morise¹, Hiroshi Sakai², Terufumi Kato³, Shingo Matsumoto⁴, Toru Kumagai⁵, Tomohiro Sakamoto⁶, Takaaki Tokito⁷, Shinji Atagi⁸, Toshiyuki Kozuki⁹, Hiroaki Takeoka¹⁰, Kenichi Chikamori¹¹, Naofumi Shinagawa¹², Hiroshi Tanaka¹³, Tomonori Hirashima¹⁴, S Peter Eggleton¹⁵, Rolf Bruns¹⁶, Gordon Otto¹⁷, Paul Paik^18,19 (1.Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2.Department of Thoracic Oncology, Saitama Cancer Center, Kitaadachi-gun, Japan, 3.Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, 4.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa City, Japan, 5.Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka City, Japan, 6.Department of Respiratory Medicine, Tottori University Hospital, Yonago City, Japan, 7.Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Japan, 8.Department of Thoracic Oncology, NHO Kinki-Chuo Chest Medical Center, Sakai City, Japan, 9.Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama City, Japan, 10.Department of Respiratory Medicine, NHO Kyushu Medical Center, Fukuoka City, Japan, 11.Department of Oncology, NHO Yamaguchi - Ube Medical Center, Ube City, Japan, 12.Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 13.Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan, 14.Department of Pulmonary Oncology, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Japan, 15.Global Clinical Development, Merck Serono Limited, Feltham, UK, a subsidiary of Merck KGaA, Darmstadt, Germany, 16.Department of Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany, 17.Global Clinical Development, Merck Healthcare KGaA, Darmstadt, Germany, 18.Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, 19.Department of Medicine, Weill Cornell Medical College, New York, NY, USA)